EyeD Pharma

EyeD Pharma is a clinical-stage pharmaceutical company based in Liège, Belgium, focused on improving the lives of people affected by ophthalmic diseases. The company develops innovative therapeutic solutions, including sustained-release micro-implants and complex therapeutics, with the aim of addressing difficult treatment regimens, reducing side effects, and supporting better patient compliance.

Its work targets significant eye-health needs across glaucoma, dry eye disease, and conditions involving inflammation at the back of the eye, including diabetic macular edema, retinal vein occlusion, and posterior uveitis. EyeD Pharma describes its pipeline as built around innovative drug-delivery systems and established active pharmaceutical ingredients, and designed to address unmet medical needs with input from internationally recognized experts. Its product candidates are intended to help prevent further vision loss and improve patients’ daily quality of life, though they remain in development.

EyeD Pharma also seeks partners to advance its research and innovation. The company shares information about its pipeline, team, careers, and collaboration opportunities, reflecting its commitment to developing new treatment options for people with eye diseases.